Pronociceptive role of peripheral and spinal 5-HT7 receptors in the formalin test

Héctor I. Rocha-González, Alfredo Meneses, Susan M. Carlton, Vinicio Granados-Soto

    Research output: Contribution to journalArticle

    76 Citations (Scopus)

    Abstract

    The possible pronociceptive role of peripheral and spinal 5-HT7 receptors in the formalin test was assessed. Local administration of 5-HT 7 (SB-269970, 2.5-77.1 nmol/paw), but not 5-HT1A (WAY-100635, 1-60 nmol/paw), receptor antagonist significantly reduced formalin-induced flinching. Local 5-hydroxytryptamine (5-HT, 3-100 nmol/paw) or 5-carboxamidotryptamine (5-CT, 0.3-3 nmol/paw) (a 5-HT7/1A receptor agonist) augmented, in a dose-dependent manner, 0.5% formalin-induced nociceptive behavior. The local pronociceptive effect of 5-HT or 5-CT was significantly reduced by SB-269970 (25 and 77.1 nmol/paw), but not by WAY-100635 (10 nmol/paw). 5-HT7 receptors were observed in myelinated and unmyelinated axons of the digital nerves in rat hindpaw. Intrathecal SB-269970 (2.5-77.1 nmol/rat) or WAY-100635 (1-50 nmol/rat) did not modify 1% formalin-induced nociceptive behavior. Spinal 5-HT (25-200 nmol/rat) significantly reduced formalin-induced flinching behavior during phase 2. At lower doses (0.1-3 nmol/rat) intrathecal 5-CT dose-dependently increased flinching during phase 2. In contrast, higher doses (10-30 nmol/rat) of 5-CT reduced formalin-induced nociceptive behavior during both phases. The spinal pronociceptive effect of 5-CT was reduced by SB-269970 (7.7-77 nmol/rat), but not by WAY-100635 (10 nmol/rat). In addition, the spinal antinociceptive effect of 5-CT was partially reversed by WAY-100635 (10 nmol/rat). The spinal antinociceptive effect of 5-HT was unaffected either by SB-269970 (77 nmol/rat) or WAY-100635 (10 nmol/rat). Data suggest that 5-HT7, but not 5-HT1A, receptors play a pronociceptive role in peripheral and spinal sites in the rat formalin test.

    Original languageEnglish (US)
    Pages (from-to)182-192
    Number of pages11
    JournalPain
    Volume117
    Issue number1-2
    DOIs
    StatePublished - Sep 2005

    Fingerprint

    Pain Measurement
    Serotonin
    Formaldehyde
    serotonin 7 receptor
    Receptor, Serotonin, 5-HT1A
    Axons
    N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide
    SB 269970

    Keywords

    • 5-HT receptor
    • 5-HT receptor
    • Hyperalgesia
    • SB-269970
    • Serotonin
    • Spinal processing

    ASJC Scopus subject areas

    • Clinical Neurology
    • Psychiatry and Mental health
    • Neurology
    • Neuroscience(all)
    • Pharmacology
    • Clinical Psychology

    Cite this

    Rocha-González, H. I., Meneses, A., Carlton, S. M., & Granados-Soto, V. (2005). Pronociceptive role of peripheral and spinal 5-HT7 receptors in the formalin test. Pain, 117(1-2), 182-192. https://doi.org/10.1016/j.pain.2005.06.011

    Pronociceptive role of peripheral and spinal 5-HT7 receptors in the formalin test. / Rocha-González, Héctor I.; Meneses, Alfredo; Carlton, Susan M.; Granados-Soto, Vinicio.

    In: Pain, Vol. 117, No. 1-2, 09.2005, p. 182-192.

    Research output: Contribution to journalArticle

    Rocha-González, HI, Meneses, A, Carlton, SM & Granados-Soto, V 2005, 'Pronociceptive role of peripheral and spinal 5-HT7 receptors in the formalin test', Pain, vol. 117, no. 1-2, pp. 182-192. https://doi.org/10.1016/j.pain.2005.06.011
    Rocha-González HI, Meneses A, Carlton SM, Granados-Soto V. Pronociceptive role of peripheral and spinal 5-HT7 receptors in the formalin test. Pain. 2005 Sep;117(1-2):182-192. https://doi.org/10.1016/j.pain.2005.06.011
    Rocha-González, Héctor I. ; Meneses, Alfredo ; Carlton, Susan M. ; Granados-Soto, Vinicio. / Pronociceptive role of peripheral and spinal 5-HT7 receptors in the formalin test. In: Pain. 2005 ; Vol. 117, No. 1-2. pp. 182-192.
    @article{ab41725d84d04ca8afaef1b43f593d01,
    title = "Pronociceptive role of peripheral and spinal 5-HT7 receptors in the formalin test",
    abstract = "The possible pronociceptive role of peripheral and spinal 5-HT7 receptors in the formalin test was assessed. Local administration of 5-HT 7 (SB-269970, 2.5-77.1 nmol/paw), but not 5-HT1A (WAY-100635, 1-60 nmol/paw), receptor antagonist significantly reduced formalin-induced flinching. Local 5-hydroxytryptamine (5-HT, 3-100 nmol/paw) or 5-carboxamidotryptamine (5-CT, 0.3-3 nmol/paw) (a 5-HT7/1A receptor agonist) augmented, in a dose-dependent manner, 0.5{\%} formalin-induced nociceptive behavior. The local pronociceptive effect of 5-HT or 5-CT was significantly reduced by SB-269970 (25 and 77.1 nmol/paw), but not by WAY-100635 (10 nmol/paw). 5-HT7 receptors were observed in myelinated and unmyelinated axons of the digital nerves in rat hindpaw. Intrathecal SB-269970 (2.5-77.1 nmol/rat) or WAY-100635 (1-50 nmol/rat) did not modify 1{\%} formalin-induced nociceptive behavior. Spinal 5-HT (25-200 nmol/rat) significantly reduced formalin-induced flinching behavior during phase 2. At lower doses (0.1-3 nmol/rat) intrathecal 5-CT dose-dependently increased flinching during phase 2. In contrast, higher doses (10-30 nmol/rat) of 5-CT reduced formalin-induced nociceptive behavior during both phases. The spinal pronociceptive effect of 5-CT was reduced by SB-269970 (7.7-77 nmol/rat), but not by WAY-100635 (10 nmol/rat). In addition, the spinal antinociceptive effect of 5-CT was partially reversed by WAY-100635 (10 nmol/rat). The spinal antinociceptive effect of 5-HT was unaffected either by SB-269970 (77 nmol/rat) or WAY-100635 (10 nmol/rat). Data suggest that 5-HT7, but not 5-HT1A, receptors play a pronociceptive role in peripheral and spinal sites in the rat formalin test.",
    keywords = "5-HT receptor, 5-HT receptor, Hyperalgesia, SB-269970, Serotonin, Spinal processing",
    author = "Rocha-Gonz{\'a}lez, {H{\'e}ctor I.} and Alfredo Meneses and Carlton, {Susan M.} and Vinicio Granados-Soto",
    year = "2005",
    month = "9",
    doi = "10.1016/j.pain.2005.06.011",
    language = "English (US)",
    volume = "117",
    pages = "182--192",
    journal = "Pain",
    issn = "0304-3959",
    publisher = "Elsevier",
    number = "1-2",

    }

    TY - JOUR

    T1 - Pronociceptive role of peripheral and spinal 5-HT7 receptors in the formalin test

    AU - Rocha-González, Héctor I.

    AU - Meneses, Alfredo

    AU - Carlton, Susan M.

    AU - Granados-Soto, Vinicio

    PY - 2005/9

    Y1 - 2005/9

    N2 - The possible pronociceptive role of peripheral and spinal 5-HT7 receptors in the formalin test was assessed. Local administration of 5-HT 7 (SB-269970, 2.5-77.1 nmol/paw), but not 5-HT1A (WAY-100635, 1-60 nmol/paw), receptor antagonist significantly reduced formalin-induced flinching. Local 5-hydroxytryptamine (5-HT, 3-100 nmol/paw) or 5-carboxamidotryptamine (5-CT, 0.3-3 nmol/paw) (a 5-HT7/1A receptor agonist) augmented, in a dose-dependent manner, 0.5% formalin-induced nociceptive behavior. The local pronociceptive effect of 5-HT or 5-CT was significantly reduced by SB-269970 (25 and 77.1 nmol/paw), but not by WAY-100635 (10 nmol/paw). 5-HT7 receptors were observed in myelinated and unmyelinated axons of the digital nerves in rat hindpaw. Intrathecal SB-269970 (2.5-77.1 nmol/rat) or WAY-100635 (1-50 nmol/rat) did not modify 1% formalin-induced nociceptive behavior. Spinal 5-HT (25-200 nmol/rat) significantly reduced formalin-induced flinching behavior during phase 2. At lower doses (0.1-3 nmol/rat) intrathecal 5-CT dose-dependently increased flinching during phase 2. In contrast, higher doses (10-30 nmol/rat) of 5-CT reduced formalin-induced nociceptive behavior during both phases. The spinal pronociceptive effect of 5-CT was reduced by SB-269970 (7.7-77 nmol/rat), but not by WAY-100635 (10 nmol/rat). In addition, the spinal antinociceptive effect of 5-CT was partially reversed by WAY-100635 (10 nmol/rat). The spinal antinociceptive effect of 5-HT was unaffected either by SB-269970 (77 nmol/rat) or WAY-100635 (10 nmol/rat). Data suggest that 5-HT7, but not 5-HT1A, receptors play a pronociceptive role in peripheral and spinal sites in the rat formalin test.

    AB - The possible pronociceptive role of peripheral and spinal 5-HT7 receptors in the formalin test was assessed. Local administration of 5-HT 7 (SB-269970, 2.5-77.1 nmol/paw), but not 5-HT1A (WAY-100635, 1-60 nmol/paw), receptor antagonist significantly reduced formalin-induced flinching. Local 5-hydroxytryptamine (5-HT, 3-100 nmol/paw) or 5-carboxamidotryptamine (5-CT, 0.3-3 nmol/paw) (a 5-HT7/1A receptor agonist) augmented, in a dose-dependent manner, 0.5% formalin-induced nociceptive behavior. The local pronociceptive effect of 5-HT or 5-CT was significantly reduced by SB-269970 (25 and 77.1 nmol/paw), but not by WAY-100635 (10 nmol/paw). 5-HT7 receptors were observed in myelinated and unmyelinated axons of the digital nerves in rat hindpaw. Intrathecal SB-269970 (2.5-77.1 nmol/rat) or WAY-100635 (1-50 nmol/rat) did not modify 1% formalin-induced nociceptive behavior. Spinal 5-HT (25-200 nmol/rat) significantly reduced formalin-induced flinching behavior during phase 2. At lower doses (0.1-3 nmol/rat) intrathecal 5-CT dose-dependently increased flinching during phase 2. In contrast, higher doses (10-30 nmol/rat) of 5-CT reduced formalin-induced nociceptive behavior during both phases. The spinal pronociceptive effect of 5-CT was reduced by SB-269970 (7.7-77 nmol/rat), but not by WAY-100635 (10 nmol/rat). In addition, the spinal antinociceptive effect of 5-CT was partially reversed by WAY-100635 (10 nmol/rat). The spinal antinociceptive effect of 5-HT was unaffected either by SB-269970 (77 nmol/rat) or WAY-100635 (10 nmol/rat). Data suggest that 5-HT7, but not 5-HT1A, receptors play a pronociceptive role in peripheral and spinal sites in the rat formalin test.

    KW - 5-HT receptor

    KW - 5-HT receptor

    KW - Hyperalgesia

    KW - SB-269970

    KW - Serotonin

    KW - Spinal processing

    UR - http://www.scopus.com/inward/record.url?scp=28844472517&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=28844472517&partnerID=8YFLogxK

    U2 - 10.1016/j.pain.2005.06.011

    DO - 10.1016/j.pain.2005.06.011

    M3 - Article

    VL - 117

    SP - 182

    EP - 192

    JO - Pain

    JF - Pain

    SN - 0304-3959

    IS - 1-2

    ER -